Position in QNCX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$86,038
+$85,983 QoQ
Shares Held
4,730
+157566.7% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 25 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Derivatives in QNCX
reported options exposure · as of Sep 30, 2021CallValue
$0
CallShares
0
PutValue
$4,601,332
PutShares
251
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. QNCX ranks #368 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in QNCX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,038 | 4,730 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $55 | 556 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $117,557 | 35,092 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,398 | 1,472 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,695 | 2,846 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $938 | 706 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,082 | 1,114 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $371 | 480 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $360 | 480 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $534 | 505 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $530 | 505 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,467 | 6,668 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,372 | 912 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $507 | 325 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,218 | 45,869 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $44,293 | 33,304 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $55,772 | 25,123 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $158,376 | 25,586 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $197,527 | 15,652 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,601,332 | 50,200 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $1,557,302 | 16,990 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $537,738 | 10,146 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,290,449 | 35,816 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $293,189 | 10,554 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,018,550 | 20,371 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,062,815 | 22,955 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,189,234 | 26,074 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||